Number of patients
|
770
|
359
|
172
|
97
|
92
|
45
|
Age (years)
|
64.6 (9.4)
|
65.6 (9.5)
|
65.4 (9.4)
|
66.0 (8.6)
|
67.3 (7.9)
|
62.4 (7.7)
|
Sex (% male)
|
58.3
|
54.0
|
69.2
|
73.2
|
65.2
|
64.4
|
Age at self reported year of diagnosis
|
54.3 (11.1)
|
56.1 (11.8)
|
60.8 (10.2)
|
61.3 (10.1)
|
63.9 (7.9)
|
56.8 (9.3)
|
311
|
145
|
121
|
69
|
51
|
25
|
Self-reported duration of disease
|
10.3 (8.4)
|
9.2 (8.2)
|
4.7 (6.6)
|
4.8 (7.6)
|
4.4 (5.4)
|
4.2 (3.7)
|
302
|
142
|
120
|
68
|
51
|
25
|
Body mass index
|
32.3 (6.2)
|
31.9 (5.7)
|
28.3 (4.1)
|
28.8 (5.1)
|
30.2 (6.6)
|
29.9 (6.9)
|
727
|
338
|
164
|
91
|
81
|
42
|
Waist circumference (M/F)
|
109.9 (14.4)/ 106.8 (15.5)
|
110.1 (12.8)/ 104.8 (15.1)
|
100.3 (11.0)/ 95.1 (12.8)
|
102.9 (11.7)/ 91.5 (12.6)
|
106.7 (12.8)/ 94.1 (14.6)
|
108.0 (17.9)/ 89.6 (17.3)
|
429/298
|
182/156
|
116/47
|
66/25
|
55/25
|
25/16
|
Systolic blood pressure (mmHg)
|
143.4 (20.0)
|
143.1 (20.2)
|
137.6 (20.5)
|
139.9 (18.2)
|
132.9 (23.7)
|
127.6 (22.7)
|
727
|
337
|
163
|
91
|
81
|
42
|
Diastolic blood pressure (mmHg)
|
84.2 (11.1)
|
84.1 (10.8)
|
81.0 (12.2)
|
82.1 (10.5)
|
81.3 (14.1)
|
80.2 (11.5)
|
727
|
338
|
163
|
91
|
81
|
42
|
Serum total cholesterol (mmol/l)
|
4.4 (1.1)
|
4.4 (0.9)
|
3.8 (0.9)
|
3.8 (1.0)
|
4.0 (1.2)
|
4.0 (1.4)
|
225
|
121
|
66
|
46
|
23
|
12
|
Serum HDL cholesterol (mmol/l)
|
1.2 (0.4)
|
1.3 (0.4)
|
1.4 (0.4)
|
1.3 (0.4)
|
1.1 (0.4)
|
1.3 (0.5)
|
219
|
119
|
65
|
45
|
23
|
11
|
Serum LDL cholesterol (mmol/l)
|
2.3 (0.8)
|
2.4 (0.8)
|
1.9 (0.6)
|
1.9 (0.7)
|
2.1 (0.9)
|
2.2 (0.9)
|
210
|
115
|
65
|
45
|
21
|
11
|
Lipid lowering medication (%)
|
24.7
|
20.3
|
60.5
|
55.7
|
38.0
|
22.2
|
190
|
73
|
104
|
54
|
35
|
10
|
Daily smokers (%)
|
12.7
|
11.0
|
11.9
|
10.1
|
12.7
|
12.2
|
88/691
|
36/327
|
19/160
|
9/89
|
10/79
|
5/41
|
Hb1Ac (%)
|
7.5 (1.1)
|
7.7 (1.7)
| | | | |
415
|
224
| | | | |
Oral antidiabetic drug and insulin (%)
|
12.3
|
13.1
| | | | |
95
|
47
| | | | |
Oral antidiabetic drug (%)
|
34.0
|
29.8
| | | | |
262
|
107
| | | | |
Insulin (%)
|
16.8
|
16.7
| | | | |
|
129
|
60
| | | | |
SCORE1
|
8.0 (6.3)
|
7.6 (7.9)
| | | | |
215
|
115
| | | | |
NYHA2
| | | | |
2.4 (1.4)
|
2.5 (1.4)
|
| | | | |
52
|
30
|